Table 3.
PHPT (n = 17) |
SHPT (n = 16) |
|||||
---|---|---|---|---|---|---|
USG | MIBI | p Value | USG | MIBI | p Value | |
Location of glands, n (%) | ||||||
Left superior | 3/17 | 2/17 | 1.000 | 13/16 | 13/16 | 1.000 |
Left inferior | 10/17 | 9/17 | .730 | 14/16 | 14/16 | 1.000 |
Right superior | 2/17 | 2/17 | 1.000 | 12/16 | 10/16 | .704 |
Right inferior | 5/17 | 3/17 | .688 | 13/16 | 10/16 | .433 |
Ectopic | 0/17 | 0/17 | / | 0/16 | 0/16 | / |
Number of enlarged glands, n (%) | ||||||
0 | 0/17 | 1/17 | 1.000 | 0/16 | 0/16 | / |
1 | 14/17 | 16/17 | 0.601 | 2/16 | 1/16 | 1.000 |
2 | 3/17 | 0/17 | .227 | 0/16 | 4/16 | .101 |
3 | 0/17 | 0/17 | / | 6/16 | 6/16 | 1.000 |
4 | 0/17 | 0/17 | / | 8/16 | 4/16 | .273 |
Total number of glands | 20 | 16 | / | 52 | 47 | / |
Note: Data are percentages and numbers. PHPT: primary hyperparathyroidism; SHPT: secondary hyperparathyroidism; USG: ultrasonography; MIBI: 99mTc sestamibi scintigraphy.
Note: Bold Numbers mean statistically significant, P < 0.05